significant melanocyte cytotoxicity was seen with vitiligo patients ' sera as an antibody source with both complement-mediated cytotoxicity ( p less than 0.01 ) and adcc ( p less than 0.05 ) as effector mechanisms .
C0229671
sera
C0009498
complement